Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination

The omicron variant carries a large number of mutations in the spike protein, with at least 15 mutations in the receptor-binding domain (RBD), the primary target of neutralizing antibodies [1]. In the comparison of the effects in booster dose between younger and older groups, there was no significan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Travel medicine and infectious disease 2023-03, Vol.52, p.102531-102531, Article 102531
Hauptverfasser:	Zhang, Yuwei, Guo, Xingyu, Han, Shanshan, Yao, Mingxiao, Zhang, Lin, Zhao, Lianxiang, Zhang, Jinzhong, Jiang, Xiangkun, Zhang, Shu, Pang, Bo, Wang, Jianxing, Wang, Shuang, Fang, Ming, Liu, Xiaolin, Kou, Zengqiang, Jiang, Xiaolin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Viral Conflicts of interest Coronaviruses COVID-19 - prevention & control COVID-19 vaccines Humans Infectious diseases Mutation Neutralization Older people Proteins R&D Receptors Research & development SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Travel medicine Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!